BEAM Beam Therapeutics

• None no insider bought on the open market
• $10M sold by 1 insider outside a trading plan
• $8.1M sold by 5 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. John M. Evans CEO
   Planned sale
   $1.2M 50,000 shares at $23.77 4.6% of stake
   Traded Oct 15–16 Filed Oct 16
   ↗
3. Amy Simon Chief Medical Officer
   Planned sale
   $429K 16,667 shares at $25.74 16% of stake
   Traded Jul 27 Filed Jul 29
   ↗
4. John M. Evans CEO
   Planned sale
   $1.7M 50,000 shares at $34.90 4.6% of stake
   Traded Jun 29–30 Filed Jul 1
   ↗
5. Fmr LLC 10% owner
   Sale
   $10M 284,860 shares at $35.24 25% of stake
   Traded Jun 25–26 Filed Jun 29
   ↗
6. John M. Evans CEO
   Planned sale
   $1.1M 50,000 shares at $22.57 4.8% of stake
   Traded Mar 30–31 Filed Apr 1
   ↗
7. Giuseppe Ciaramella President
   Planned sale
   $1.1M 35,000 shares at $32.00 16% of stake
   Traded Feb 24 Filed Feb 26
   ↗
8. John M. Evans CEO
   Planned sale
   $1.4M 50,000 shares at $28.87 4.8% of stake
   Traded Jan 29–30 Filed Feb 2
   ↗
9. Bethany J Cavanagh SVP, Finance and Treasurer
   Planned sale
   $217K 6,198 shares at $35.00 15% of stake
   Traded Jan 22 Filed Jan 26
   ↗
10. Christine Bellon Chief Legal Officer
    Planned sale
    $47K 1,371 shares at $34.00 1.4% of stake
    Traded Jan 22 Filed Jan 26
    ↗
11. Bethany J Cavanagh SVP, Finance and Treasurer
    Planned sale
    $91K 3,034 shares at $30.12 6.9% of stake
    Traded Jan 20 Filed Jan 21
    ↗
12. Christine Bellon Chief Legal Officer
    Planned sale
    $645K 18,629 shares at $34.61 16% of stake
    Traded Jan 15 Filed Jan 20
    ↗
13. Fmr LLC 10% owner
    Sale
    $12K 459 shares at $26.68 97% of stake
    Traded Oct 27, 2025 Filed Oct 29, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 option exercises, 9 sales to cover taxes, 7 stock grants, and 1 gift.